The ZandCell effort consists of technology development in Europe aimed at the production, expansion, and differentiation of pluripotent stem cells. Our program involves the use of embryonical stem cells but bypassing the need for creating and then destroying human embryos or fetal tissues. It should be noted that this proprietary method does not provide the ability to create an embryo, and thus is not “therapeutic cloning.” Our technology represents a new paradigm for the generation of stem cells.

The company has made significant progress in developing tolerogenic cells from differentiated stem cells, and has patented this technology. In addition, therapeutic cell lines will be developed for diabetes as well as neuronal cell applications (Alzheimer’s, Parkinson’s, and spinal cord repair).

Why should you consider Regenerate Stem Cell Therapy from ZandCell?

The ZandCell stem cell technology is in our view superior to any technology used presently by any stem cell clinic elsewhere. It is safer, more effective and less expensive. Without entering into details, suffice to say that ZandCells technology eliminates the long process of extracting stem cells from blood or others from the donor’s body, grow these cell in a tissue culture, where they might became contaminated, and after 4-5 weeks, re-inject them back in the donor’s body where they will repair or restore, only the targeted organ or tissue they were derived from. This explanation is, rather simplistic since there are many other players involved but it is in essence accurate.


For further questions, please feel free to contact us.